✦ LIBER ✦

Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines

✍ Scribed by Ingo B. Runnebaum; Xiao-Wen Tong; Volker Moebus; Volker Heilmann; Dirk G. Kieback; Rolf Kreienberg

Publisher: Springer
Year: 1994
Tongue: English
Weight: 793 KB
Volume: 93
Category: Article
ISSN: 0340-6717
DOI: 10.1007/bf00201559

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of deletions and insertio

Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: Application to breast and ovarian tumors

✍ Katerina Angelopoulou; Eleftherios P. Diamandis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

We have developed a simple and highly efficient method to detect deletions and insertions in the p53 gene. All 11 exons of the p53 gene were amplified along with a control sequence in four multiplex PCR reactions in the presence of fluorescein-labeled primers. The PCR products were resolved on an au

Decreased cytotoxic effects of doxorubic

Decreased cytotoxic effects of doxorubicin in a human ovarian cancer-cell line expressing wild-type p53 and WAF1/CIP1 genes

✍ Faina Vikhanskaya; Maurizio D'Incalcimassimo Broggini 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 936 KB

The cytotoxicity of Doxorubicin and cis-dichloro-diammineplatinum (DDP) was evaluated in clones, obtained from a human ovarian cancer cell line transfected with a ternperaturesensitive p53 mutant, which express mutant p53 at 37°C and wild-type-like p53 at 32°C. DDP was equally active in cells not ex

Apoptotic response to camptothecin and 7

Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways

✍ Wilberto Nieves-Neira; Yves Pommier 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB 👁 2 views

Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce